Type I Interferon Receptor Subunit 1 Deletion Attenuates Experimental Abdominal Aortic Aneurysm Formation

Biomolecules. 2022 Oct 21;12(10):1541. doi: 10.3390/biom12101541.

Abstract

Objective: Type I interferon receptor signaling contributes to several autoimmune and vascular diseases such as lupus, atherosclerosis and stroke. The purpose of this study was to assess the influence of type I interferon receptor deficiency on the formation and progression of experimental abdominal aortic aneurysms (AAAs).

Methods: AAAs were induced in type I interferon receptor subunit 1 (IFNAR1)-deficient and wild type control male mice via intra-infrarenal aortic infusion of porcine pancreatic elastase. Immunostaining for IFNAR1 was evaluated in experimental and clinical aneurysmal abdominal aortae. The initiation and progression of experimental AAAs were assessed via ultrasound imaging prior to (day 0) and days 3, 7 and 14 following elastase infusion. Aneurysmal histopathology was analyzed at sacrifice.

Results: Increased aortic medial and adventitial IFNAR1 expression was present in both clinical AAAs harvested at surgery and experimental AAAs. Following AAA induction, wild type mice experienced progressive, time-dependent infrarenal aortic enlargement. This progression was substantially attenuated in IFNAR1-deficient mice. On histological analyses, medial elastin degradation, smooth muscle cell depletion, leukocyte accumulation and neoangiogenesis were markedly diminished in IFNAR1-deficient mice in comparison to wild type mice.

Conclusion: IFNAR1 deficiency limited experimental AAA progression in response to intra-aortic elastase infusion. Combined with clinical observations, these results suggest an important role for IFNAR1 activity in AAA pathogenesis.

Keywords: abdominal aortic aneurysm; angiogenesis; leukocytes; type I interferon receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aortic Aneurysm, Abdominal* / genetics
  • Aortic Aneurysm, Abdominal* / metabolism
  • Disease Models, Animal
  • Elastin
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pancreatic Elastase
  • Receptor, Interferon alpha-beta / genetics
  • Swine

Substances

  • Receptor, Interferon alpha-beta
  • Elastin
  • Pancreatic Elastase

Grants and funding

This work was supported in part by the Walter C. and Elsa R. Chidester and Department of Surgery at Stanford University, and the National Science Foundation of China (81873525 & 81600256). Other support was provided by the China Scholarship Council (Gang Li, Yankui Li, Sihai Zhao), Shanxi Medical University First Hospital Postdoctoral Research Fellowship (Jia Guo), National Specialized Clinical Center Program for Endocrinology at Chongqing Medical University (Xiaoya Zheng), Kyorin University Research Fellowship (Toru Ikezoe) and Fukuda Foundation for Medical Technology (Takahiro Shoji).